Literature DB >> 26588240

Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades.

Sue Yazaki Sun1, Alexander Melamed, Naima T Joseph, Allison Ann Gockley, Donald Peter Goldstein, Marilyn R Bernstein, Neil S Horowitz, Ross Stuart Berkowitz.   

Abstract

OBJECTIVE: The aim of this study was to compare the clinical presentation and incidence of postmolar gestational trophoblastic neoplasia (GTN) among cases of complete mole (CM) and partial mole (PM) from 1994 to 2013.
METHODS: This study included all cases of patients with CM and PM from our trophoblastic disease center between 1994 and 2013. Their clinical and pathologic reports were reviewed. Gestational age at evacuation, features of clinical presentation, human chorionic gonadotropin levels, and the rate of progression to GTN were compared.
RESULTS: The median gestational age at evacuation was 9 weeks for CM and 12 weeks for PM (P < 0.001). Patients with PM had lower pre-evacuation serum human chorionic gonadotropin levels (P < 0.001), and they were also less likely to present with vaginal bleeding (P < 0.001), biochemical hyperthyroidism (P < 0.001), anemia (P < 0.001), uterine size greater than dates (P < 0.001), and hyperemesis (P = 0.002). Consequently, patients with PM were less likely to have been clinically diagnosed as moles compared with CM prior to uterine evacuation (P < 0.001). The development of GTN occurred in 17.7% (33/186) and 4.1% (7/169) of patients with CM and PM, respectively (P < 0.001).
CONCLUSIONS: This study indicates that, at our center over the past 20 years, both CM and PM were usually evacuated in the first trimester of pregnancy. Because CM more commonly presents with the signs and symptoms of molar disease than PM, CM is more commonly diagnosed prior to evacuation.

Entities:  

Mesh:

Year:  2016        PMID: 26588240     DOI: 10.1097/IGC.0000000000000608

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.

Authors:  Peng Zhao; Qinqing Chen; Weiguo Lu
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

2.  Incidence and outcome of gestational trophoblastic disease in lower Egypt.

Authors:  Ahmed Zakaria; Reda Hemida; Waleed Elrefaie; Ehsan Refaie
Journal:  Afr Health Sci       Date:  2020-03       Impact factor: 0.927

3.  Severe Hyperthyroidism and Complete Hydatidiform Mole in Perimenopausal Woman: Case Report and Literature Review.

Authors:  Tiago Da Silva Santos; Sílvia Santos Monteiro; Maria Teresa Pereira; Susana Garrido; Manuela Leal; Carina Andrade; Joana Vilaverde; Jorge Dores
Journal:  Cureus       Date:  2022-02-15

4.  Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study.

Authors:  Marisa Victoria Diniz; Sue Y Sun; Claudia Barsottini; Mauricio Viggiano; Roney C Signorini Filho; Bruna Sanches Ozane Pimenta; Kevin M Elias; Neil S Horowitz; Antonio Braga; Ross S Berkowitz
Journal:  J Med Internet Res       Date:  2018-09-24       Impact factor: 5.428

5.  Successful Management of the First Case of a Metastasized Complete Mole in Form of Twin Pregnancy in Jordan.

Authors:  Amer Sindiani; Basil Obeidat; Eman Alshdaifat
Journal:  Am J Case Rep       Date:  2020-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.